Artificial Intelligence (AI) in Life Sciences Market
Report Scope:
This report aims to comprehensively study the market size of global artificial intelligence (AI) in the life sciences. Current and historical market revenues can be estimated based on products, applications, end users, and regions.
Report Includes:
26 data tables and 35 additional tables
Analyses of trends in the global market for AI in life sciences, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the current market size and revenue prospects, along with a market share analysis based on product segment, application, end user and region
Facts and figures pertaining to the market dynamics, current and emerging technologies, regulatory scenario and the expected impact of macroeconomic factors
Identification of the AI products and technologies with the highest commercial potential, and their relevant applications in life sciences, specifically precision medicine and personalized healthcare
Overview of ESG developments and sustainability trends, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
Review of patent activity and key patent grants
An analysis of the industry structure, including companies’ market shares, merger and acquisition activity, and venture funding outlook
Profiles of the leading companies, including AiCure LLC., Apixio Inc., Atomwise Inc., BenevolentAI and NuMedii Inc.
Companies Mentioned
AICURE APIXIO ATOMWISE INC. BENEVOLENTAI ENLITIC INC. NUMEDII INC. RECURSION ZEBRA TECHNOLOGIES CORP.